Actively Recruiting
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
Led by Beijing Friendship Hospital · Updated on 2026-03-02
186
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to investigate the effects of a perioperative multimodal rehabilitation program on the incidence of postoperative complications and perioperative clinical indexes including functional capacity, nutritional and psychological status in patients with gastric cancer undergoing neoadjuvant therapy. Besides the investigators also develop a smart phone based digital platform aiming to evaluate its effectiveness in improving patient adherence, compared with the conventional telephone supervision approach. The main questions it aims to answer are: * Can the perioperative multimodal rehabilitation program reduce postoperative complications in patients with gastric cancer undergoing neoadjuvant therapy? * Can the smart phone based digital platform improve patients' adherence compared to traditional telephone supervision? * Can the perioperative multimodal rehabilitation program improve the perioperative clinical indicators of patients with gastric cancer undergoing neoadjuvant therapy, including functional capacity, nutritional status and psychological condition? The investigators will compare the perioperative multimodal rehabilitation program with the standard treatment alone to determine whether this program has the effects mentioned above. Participants will follow the perioperative multimodal rehabilitation program from neoadjuvant therapy through to four weeks after discharge.
CONDITIONS
Official Title
Digital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged between 18 and 70 years
- Histologically confirmed resectable adenocarcinoma of the oesophago gastric junction or stomach
- Referred by a multidisciplinary team for neoadjuvant therapy
- Able to use a smartphone and willing to comply with regular follow-up assessments
- Provided written informed consent
You will not qualify if you...
- Presence of distant metastasis
- Severe cardiopulmonary disease or other conditions preventing exercise or walking tests
- Having other concurrent malignant tumors
- Suspected recurrent gastric cancer
- Cognitive, communication, or psychiatric issues preventing study compliance
- Women who are pregnant, breastfeeding, or planning pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Friendship Hospital, Capital Medical University
Beijing, China
Actively Recruiting
Research Team
Z
Zhi Zheng, Attending surgon
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here